Researchers identified 8 immune cell phenotypes that demonstrated causal associations with gout risk: 5 protective and 3 linked to increased risk. Interactions between immune cell phenotypes and gut ...

Clinicians from Fox Chase Cancer Center at Temple University Health share their highlights from the Society of Urologic ...

Post hoc trial findings support aprocitentan’s potential cardiovascular and kidney-protective effects in patients with chronic kidney disease (CKD) with resistant hypertension.

Authors say health professionals should increase the presence of reliable content. (HealthDay News) — TikTok videos about gout may not be accurate, according to a study published online Dec. 10 in ...

GLP-1 RA therapy linked to significantly lower risk for epilepsy compared with DPP4-i use among adults with T2DM. (HealthDay News) — For adults with type 2 diabetes mellitus (T2DM), glucagon-like ...

Five diabetes subgroups (MARD, MOD, SAID, SIDD, SIRD) have specific comorbidity and mortality risk profiles, study results show.

ADT speeds coronary atherosclerosis, with greater effects with use of the GnRH-agonist leuprolide compared with the GnRH-antagonist relugolix. Coronary atherosclerosis may progress more over 12 months ...

MRI is the ideal imaging modality for initial evaluation and diagnosis of testicular cancer.

Researchers found no significant difference in the magnitude of urate volume reduction between joint and tendon deposits over 1 year among patients receiving ULT. Among patients with gout receiving ...

Pain and symptom severity scores significantly higher in patients with fibromyalgia and OAB. (HealthDay News) — Overactive bladder (OAB) is prevalent among women with fibromyalgia (FM) and is ...

Variance in incidence seen across cancer types, but consistently increased with later stage at initial diagnosis. (HealthDay News) — Nearly one in 10 adolescent and young adult patients diagnosed with ...

In patients with BRCA2-mutated mCSPC, treatment with Akeega significantly reduced the risk of radiographic progression or death by 54%. The Food and Drug Administration (FDA) has approved Akeega ® ...